Additional file 1 of Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetes

Additional file 1: Table S1. Coronary angiography findings and rates of revascularization within 30 days following procedure across hs-cTnT quartiles. Table S2A. Major adverse cardiac event (MACE) risk according to quartiles of hs-cTnT with additional adjustments in the entire prediabetes cohort. Table S2B. All-cause mortality according to quartiles of hs-cTnT with additional adjustments in the entire prediabetes cohort. Table S3A. Major adverse cardiac event (MACE) risk according to quartiles of hs-cTnT with additional adjustments in secondary prevention subjects. Table S3B. All-cause mortality according to quartiles of hs-cTnT with additional adjustments in secondary prevention subjects. Table S4A. Major adverse cardiac event (MACE) risk according to pooled quartiles 1, 2 and 3 vs. quartile 4 of hs-cTnT with additional adjustments in primary prevention subjects. Table S4B. All-cause mortality risk according to pooled quartiles 1, 2 and 3 vs. quartile 4 of hs-cTnT with additional adjustments in primary prevention subjects. Table S5A. Major adverse cardiac event (MACE) risk according to quartiles of hs-cTnT with additional adjustments in the entire prediabetes cohort excluding those who underwent coronary revascularization within 30 days after angiography. Table S5B. All-cause mortality according to quartiles of hs-cTnT with additional adjustments in the entire prediabetes cohort excluding those who underwent coronary revascularization within 30 days after angiography.